Bookmark

Add to MyYahoo RSS

Halozyme Therapeutics News

News on Halozyme Therapeutics (Ticker: HALO) continually updated from thousands of sources around the net.

Tuesday | Applied Clinical Trials

Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer

PEGPH20 is an investigational PEGylated form of Halozyme's proprietary recombinant human hyaluronidase under development for the systemic treatment of tumors that accumulate hyaluronan.

Comment?

Related Topix: Pancreatic Cancer, Health, Biotech, Healthcare Law, Law, Oncology

Wed Jun 25, 2014

Freshnews

Roche's Commercial Launch Of MabThera SC Triggers Milestone Payment To Halozyme

Halozyme Therapeutics, Inc. announced today that the commercial launch of MabThera SC in Europe has triggered a $5 million milestone payment to Halozyme during the second quarter under the License and Collaboration Agreement between Halozyme and Roche.

Comment?

Related Topix: Biotech, Oncology, Lymphoma, Health

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••